Alimera Sciences Inc reports results for the quarter ended in March - Earnings Summary

Alimera Sciences

09/05/2022 14:32

* Alimera Sciences Inc  ALIM.OQ  reported a quarterly
adjusted
loss of 85 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 69 cents per share.
    * Revenue rose 6.1% to $11.90 million from a year ago; 
analysts
expected $12.90 million. 
    * The mean earnings estimate of analysts had fallen by
about 51.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Alimera Sciences Inc shares had fallen by 2.7% this
quarter and
gained 6.2% so far this year.
    * The company reported a quarterly loss of $5.96 million.
    * Wall Street's median 12-month price target for Alimera
Sciences
Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 9 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated